Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 28, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 9 April 2026 - 9:12

Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 28, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/darzalex

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters